American Vanguard (AVD) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
7 Aug, 2025Executive summary
Adjusted EBITDA nearly doubled year-over-year to $11 million, driven by operational improvements and business transformation initiatives, with gross profit margin reaching a five-quarter high of 31%.
Net sales for Q2 2025 increased 1% year-over-year to $129 million, with domestic sales up 1% and international sales flat.
Operating expenses declined significantly, with reductions in transformation and research costs, resulting in a Q2 operating profit of $4.4 million versus a $9.2 million loss last year.
Net loss for Q2 2025 was $0.8 million ($0.03/share), a substantial improvement from $11.7 million ($0.42/share) loss in Q2 2024.
Management remains optimistic about continued improvement, emphasizing that current results are only the beginning of a broader transformation.
Financial highlights
Q2 2025 net sales: $129.3 million (up 1% year-over-year); gross profit: $40.5 million (up 7%); gross margin: 31%.
Adjusted EBITDA for Q2 2025 was $11 million, up from $6 million in Q2 2024; EBITDA margin rose to 9% from 5%.
Operating expenses for Q2: $36.2 million (down 23% year-over-year); transformation costs fell 78%.
Inventory at quarter-end was $191 million, down $53 million year-over-year, improving cash flow and reducing reliance on credit lines.
Debt outstanding at June 30, 2025: $189 million, down from $211 million a year ago.
Outlook and guidance
2025 EBITDA target reaffirmed at $40–$44 million and revenue target at $535–$545 million.
Management expects further improvements in gross profit, inventory, and working capital as SIOP plan is optimized.
Double-digit growth expected from green solutions in 2025, with Central and South American sales anticipated to strengthen in the second half.
Free cash flow for 2025 projected to be strong, with most used to pay down debt.
Management expects continued expense control and further inventory reduction in coming quarters.
Latest events from American Vanguard
- 2025 margins improved and losses narrowed; 2026 targets higher EBITDA and growth from new products.AVD
Q4 202516 Mar 2026 - Q2 sales and margins fell, guidance was cut, and transformation and cost-saving efforts accelerated.AVD
Q2 20242 Feb 2026 - Q3 loss and sales drop driven by recall, but guidance and non-crop growth remain strong.AVD
Q3 202415 Jan 2026 - Transformation plan aims for 15% EBITDA margin and growth in biologicals by 2025.AVD
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025 - 2024 EBITDA met guidance as debt and inventory fell; 2025 targets higher revenue and margin.AVD
Q4 202424 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve performance-based executive pay.AVD
Proxy Filing2 Dec 2025 - Adjusted EBITDA up 350%, gross margin 29%, and net loss narrowed on strong U.S. crop sales.AVD
Q3 202517 Nov 2025 - Q1 sales dropped 14% with a net loss, but cost cuts and lower debt support recovery.AVD
Q1 202514 Nov 2025